Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]

  • Awaiting development
  • GID-TA10718
  • Expected publication date: TBC

Status:
Awaiting development
Decision:
None selected
Process:
TA
ID number:
3833

For further information on our processes and methods, please see our CHTE processes and methods manual